In The News Posted April 26, 2019 Share Posted April 26, 2019 SILVER SPRING, Md., April 26, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Benlysta (belimumab) intravenous (IV) infusion for treatment of children with systemic lupus erythematosus (SLE) – often referred to as simply "lupus" – a serious chronic disease that... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.